Dysprosium Chloride as a Nonabsorbable Gastrointestinal Marker for Studies of Stable Isotope-Labeled Triglyceride Excretion in Man
Sally A. Schuette, PhD,
Morteza Janghorbani, PhD,
Mitchell B. Cohen, MD,
Susan Krug, MS, RD,
Terri Schindler, RD, LD,
David A. Wagner, PhD and
Steven J. Morris, PhD
BioChemAnalysis Corp (S.A.S., M.J.)
Center for Stable Isotope Research Inc (M.J.), Chicago, Illinois
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio (M.B.C., S.K., T.S.)
Metabolic Solutions Inc., Nashua, New Hampshire (D.A.W.)
University of Missouri, Columbia, Missouri (S.J.M.)

View larger version (25K):
[in a new window]
|
Fig. 1. Observed correlation between excretion of 13C* and Dy (r2 = 0.969); dashed line represents the line of identity. The data include 39 stools from nine cystic fibrosis patients ( ) and 16 stools from three tests in a single healthy adult ().
|
|
Copyright © 2003 by the American College of Nutrition.